Methods for inhibiting angiogenesis
    2.
    发明申请
    Methods for inhibiting angiogenesis 审中-公开
    抑制血管发生的方法

    公开(公告)号:US20060079538A1

    公开(公告)日:2006-04-13

    申请号:US11129006

    申请日:2005-05-12

    IPC分类号: A61K31/52

    CPC分类号: A61K31/52 A61K31/517

    摘要: The invention relates generally to methods for inhibiting angiogenesis. More particularly, methods for inhibiting angiogenesis comprise selectively inhibiting phosphoinositide 3-kinase delta (PI3Kδ) activity in endothelial cells. The methods may comprise administration of one or more cytotoxic therapies including but not limited to radiation, chemotherapeutic agents, photodynamic therapies, radiofrequency ablation, anti-angiogenic agents, and combinations thereof.

    摘要翻译: 本发明一般涉及抑制血管发生的方法。 更具体地,抑制血管生成的方法包括选择性抑制内皮细胞中的磷酸肌醇3-激酶δ(PI3Kdelta)活性。 所述方法可以包括施用一种或多种细胞毒性疗法,包括但不限于放射剂,化学治疗剂,光动力疗法,射频消融,抗血管生成剂及其组合。

    Inhibitors of human phosphatidylinositol 3-kinase delta
    9.
    发明授权
    Inhibitors of human phosphatidylinositol 3-kinase delta 有权
    人类磷脂酰肌醇3-激酶三角体抑制剂

    公开(公告)号:US06800620B2

    公开(公告)日:2004-10-05

    申请号:US10337192

    申请日:2003-01-06

    IPC分类号: A61K3133

    摘要: Methods of inhibiting phosphatidylinositol 3-kinase delta isoform (PI3K&dgr;) activity, and methods of treating diseases, such as disorders of immunity and inflammation, in which PI3K&dgr; plays a role in leukocyte function are disclosed. Preferably, the methods employ active agents that selectively inhibit PI3K&dgr;, while not significantly inhibiting activity of other PI3K isoforms. Compounds are provided that inhibit PI3K&dgr; activity, including compounds that selectively inhibit PI3K&dgr; activity. Methods of using PI3K&dgr; inhibitory compounds to inhibit cancer cell growth or proliferation are also provided. Accordingly, the invention provides methods of using PI3K&dgr; inhibitory compounds to inhibit PI3K&dgr;-mediated processes in vitro and in vivo.

    摘要翻译: 公开了抑制磷脂酰肌醇3-激酶δ同种型(PI3Kdelta)活性的方法,以及治疗PI3Kdelta在白细胞功能中起作用的疾病如免疫和炎症疾病的方法。 优选地,所述方法使用选择性抑制PI3Kdelta的活性剂,而不显着抑制其它PI3K同种型的活性。 提供抑制PI3Kdelta活性的化合物,包括选择性抑制PI3Kdelta活性的化合物。 还提供了使用PI3Kdelta抑制化合物抑制癌细胞生长或增殖的方法。 因此,本发明提供了使用PI3Kdelta抑制化合物在体外和体内抑制PI3Kdelta介导的过程的方法。